title: TBI, etoposide and cyclophosphamide as a promising conditioning regimen for BMT in childhood ALL in second remission.
authors.forename: E
authors.initials: E
authors.lastname: Biagi
authors.forename: A
authors.initials: A
authors.lastname: Rovelli
authors.forename: A
authors.initials: A
authors.lastname: Balduzzi
authors.forename: P
authors.initials: P
authors.lastname: De Lorenzo
authors.forename: A
authors.initials: A
authors.lastname: Tagliabue
authors.forename: C
authors.initials: C
authors.lastname: Uderzo
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D016026:Bone Marrow Transplantation; D002648:Child; D003520:Cyclophosphamide / Q000008:administration & dosage; D003561:Cytarabine / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D005260:Female; D006801:Humans; D015255:Idarubicin / Q000008:administration & dosage; D008297:Male; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000628:therapy*; D019172:Transplantation Conditioning / Q000379:methods*; D014916:Whole-Body Irradiation
chemical_list: D003561:Cytarabine; D005047:Etoposide; D003520:Cyclophosphamide; D015255:Idarubicin